S
Spravato
Analyzing
Extracting target signal
Spravato
Extracting target signal
Spravato
Arcmira media summary
Browse Spravato reviews, demos & launch coverage — 4 indexed from Bloomberg Television & Empire, updated May 2026.
An FDA-approved nasal spray treatment for treatment-resistant depression.
An approved ketamine-based drug for depression.
the spado nose spray it's the only form of ketamine that's FDA approved for depression
Arcmira tracks 4 indexed media appearances or mentions for Spravato, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine" with transcript-derived context and links when available.
Spravato is connected to treatment resistant depression, psychedelic medicine, Psychedelics in Arcmira's media graph.
4
Mentions
41.6K
Views
The trendline is visible, but the dated evidence behind Spravato is in the premium layer.
“An FDA-approved nasal spray treatment for treatment-resistant depression.”
“An approved ketamine-based drug for depression.”
“the spado nose spray it's the only form of ketamine that's FDA approved for depression”